BRII BIOSCIENCES L
(HKEX: 2137)
Brii Biosciences Ltd. engages in advancing therapies for significant infectious diseases and other illnesses which have significant public health burdens. The firm also focuses on developing therapies for infectious diseases and central nervous system diseases. The company was founded by Zhi Hong on December 8, 2017, and is headquartered in Beijing, China.
1.490 -
-0.050
(-3.25%)
价格区间
1.480 - 1.540
(4.05%)
开盘
1.540
昨收
1.540
买
1.490
买盘
('000)
23
卖
1.510
卖盘
('000)
120
成交量
('000)
529
成交额
792,145
注释
-
数据延迟。最后一次更新12 Feb 2026 16:08.
数据提供商
查看所有活动
Loading Chart...
Please login to view stock data and analysis
